Tatiana V. Kharlamova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tatiana V. Kharlamova has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Irina V. Barysheva
RUDN University
3 shared publications - Elena Yu. Burdova
RUDN University
2 shared publications - Nadezhda A. Polovinkina
RUDN University
2 shared publications - Vladislav V. Konnov
Infectious Clinical Hospital No 2, Moscow
2 shared publications - Голуб Вениамин Петрович
People's Friendship University of Russia
2 shared publications - Татьяна Владимировна Харламова
Российский университет дружбы народов имени Патриса Лумумбы
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Epidemiology and Infectious Diseases
- Vol. 31 (3) , 239-246
Severe Astrakhan spotted fever: a case report
Astrakhan spotted fever is an acute natural-focal vector-borne disease from the group of tick-borne rickettsioses. Astrakhan Oblast is a highly endemic region for Astrakhan spotted fever. In recent years, the incidence of Astrakhan spotted fever in the Russian Federation has decreased. However, severe forms of the disease with complications, including fatal outcomes, have become more frequent. This article presents a clinical case of complicated Astrakhan spotted fever in a female patient who arrived from the Astrakhan region. The disease began acutely with an increase in body temperature to febrile levels, symptoms of intoxication, severe myalgia, and arthralgia. She self-medicated and did not seek medical help. Because of her deteriorating condition, she was hospitalized by an emergency medical team on the seventh day of illness in serious condition to the intensive care unit with a referral diagnosis of “Generalized bacterial infection. Infectious-toxic shock?” Based on clinical and epidemiological data and laboratory and instrumental studies, severe Astrakhan spotted fever was suspected. Complications: infectious-toxic shock; bilateral interstitial pneumonia of unclear etiology. Differential diagnosis was performed for generalized bacterial infection, leptospirosis, hemorrhagic fever with renal syndrome, and neuroinfection. The diagnosis of Astrakhan spotted fever was confirmed by polymerase chain reaction: Rickettsia conorii subsp. caspia DNA was detected at a concentration of 106 copies/mL. In the intensive care unit, comprehensive intensive therapy was administered, including infusion and transfusion support with correction of volemic and electrolyte disturbances, combined broad-spectrum antibacterial therapy augmented with doxycycline 200 mg/day, inotropic agents, and respiratory support. Extracorporeal detoxification methods were used, including prolonged low-flow veno-venous hemodiafiltration with selective endotoxin sorption, transfusion of fresh frozen plasma and platelet concentrate. On the 26th day of hospitalization, the patient was discharged in satisfactory condition for follow-up by an infectious disease specialist at her place of residence. Given the growth of domestic tourism in the Russian Federation, the risk of importing tick-borne rickettsioses to non-endemic regions remains high. This necessitates a cautious approach by general practitioners and infectious disease specialists toward natural-focal infections, particularly Astrakhan spotted fever.
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Epidemiology and Infectious Diseases
- Vol. 31 (3) , 239-246
Open AccessSevere Astrakhan spotted fever: a case report
Astrakhan spotted fever is an acute natural-focal vector-borne disease from the group of tick-borne rickettsioses. Astrakhan Oblast is a highly endemic region for Astrakhan spotted fever. In recent years, the incidence of Astrakhan spotted fever in the Russian Federation has decreased. However, severe forms of the disease with complications, including fatal outcomes, have become more frequent. This article presents a clinical case of complicated Astrakhan spotted fever in a female patient who arrived from the Astrakhan region. The disease began acutely with an increase in body temperature to febrile levels, symptoms of intoxication, severe myalgia, and arthralgia. She self-medicated and did not seek medical help. Because of her deteriorating condition, she was hospitalized by an emergency medical team on the seventh day of illness in serious condition to the intensive care unit with a referral diagnosis of “Generalized bacterial infection. Infectious-toxic shock?” Based on clinical and epidemiological data and laboratory and instrumental studies, severe Astrakhan spotted fever was suspected. Complications: infectious-toxic shock; bilateral interstitial pneumonia of unclear etiology. Differential diagnosis was performed for generalized bacterial infection, leptospirosis, hemorrhagic fever with renal syndrome, and neuroinfection. The diagnosis of Astrakhan spotted fever was confirmed by polymerase chain reaction: Rickettsia conorii subsp. caspia DNA was detected at a concentration of 106 copies/mL. In the intensive care unit, comprehensive intensive therapy was administered, including infusion and transfusion support with correction of volemic and electrolyte disturbances, combined broad-spectrum antibacterial therapy augmented with doxycycline 200 mg/day, inotropic agents, and respiratory support. Extracorporeal detoxification methods were used, including prolonged low-flow veno-venous hemodiafiltration with selective endotoxin sorption, transfusion of fresh frozen plasma and platelet concentrate. On the 26th day of hospitalization, the patient was discharged in satisfactory condition for follow-up by an infectious disease specialist at her place of residence. Given the growth of domestic tourism in the Russian Federation, the risk of importing tick-borne rickettsioses to non-endemic regions remains high. This necessitates a cautious approach by general practitioners and infectious disease specialists toward natural-focal infections, particularly Astrakhan spotted fever.
- Open Access
- 30 June 2025
- Published by ECO-Vector LLC (Publications) in Epidemiology and Infectious Diseases
- Vol. 30 (1) , 53-60
Dengue fever in pregnant women: two case reports
Dengue fever is a zoonotic, vector-borne infectious disease caused by four distinct serotypes of the dengue virus (DENV 1–4). This infection has been reported in 128 countries with tropical and subtropical climates. Clinical manifestations range from mild symptoms to dengue hemorrhagic fever and dengue shock syndrome with severe clinical manifestations. Dengue virus infection during pregnancy can lead to various complications affecting both the mother and the fetus. In severe cases of dengue fever in pregnant women, the most common complications include preterm birth and low birth weight. In contrast, infection during early pregnancy is not associated with fetal malformations or long-term consequences, but may result in miscarriage during the first trimester. This article presents two case reports of dengue fever in pregnant women returning from an endemic region. Both patients had traveled to Thailand and reported insect bites. The disease followed an uncomplicated course and resolved with recovery. Both pregnancies resulted in the delivery of full-term healthy infants.
- 30 June 2025
- Published by ECO-Vector LLC (Publications) in Epidemiology and Infectious Diseases
- Vol. 30 (1) , 53-60
Open AccessDengue fever in pregnant women: two case reports
Dengue fever is a zoonotic, vector-borne infectious disease caused by four distinct serotypes of the dengue virus (DENV 1–4). This infection has been reported in 128 countries with tropical and subtropical climates. Clinical manifestations range from mild symptoms to dengue hemorrhagic fever and dengue shock syndrome with severe clinical manifestations. Dengue virus infection during pregnancy can lead to various complications affecting both the mother and the fetus. In severe cases of dengue fever in pregnant women, the most common complications include preterm birth and low birth weight. In contrast, infection during early pregnancy is not associated with fetal malformations or long-term consequences, but may result in miscarriage during the first trimester. This article presents two case reports of dengue fever in pregnant women returning from an endemic region. Both patients had traveled to Thailand and reported insect bites. The disease followed an uncomplicated course and resolved with recovery. Both pregnancies resulted in the delivery of full-term healthy infants.
- Open Access
- 1 March 2024
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 29 (1) , 74-81
A case of a combined course of typhoid fever and leptospirosis
Coinfections are becoming increasingly relevant and urgently require research. The development of international tourism has caused the rapid spread of infectious diseases from countries with unfavorable sanitary and hygienic conditions. This article analyzes the clinical case of a patient who recently returned from India and developed a combined course of typhoid fever and leptospirosis due to astrovirus infection and blastocystosis. The disease was characterized by symptoms of enteritis, low-grade fever, and mild intoxication. The patient repeatedly sought medical help. Diagnoses of “acute respiratory viral infection” and “intestinal infection of unknown etiology” were established. Symptomatic therapy was performed without a positive effect; fever and severe asthenic syndrome persisted. The patient was hospitalized on the 18th day of illness with moderate severity. Taking into account clinical, anamnestic, and epidemiological data and laboratory examination results, typhoid fever was diagnosed. A polymerase chain reaction (PCR) test identified astrovirus RNA in the stool, and Blastocystis hominis was detected during stool examination. Despite the ongoing pathogenetic and antibacterial therapy, considering the determination of the pathogen’s sensitivity to antibiotics, the patient’s condition worsened. On day 23 of the illness, jaundice, hemorrhagic syndrome, and signs of acute renal failure were noted. Through in-depth analysis of changes in the clinical and laboratory findings, considering epidemiological history data (stay in a region endemic for leptospirosis), leptospirosis was diagnosed and treated with antibacterial therapy. Complex intensive therapy using extracorporeal treatment methods helped prevent the development of unfavorable outcomes of combined pathology. This clinical case emphasizes that doctors must be wary of imported infections and conduct additional comprehensive investigations of suspected cases.
- 1 March 2024
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 29 (1) , 74-81
Open AccessA case of a combined course of typhoid fever and leptospirosis
Coinfections are becoming increasingly relevant and urgently require research. The development of international tourism has caused the rapid spread of infectious diseases from countries with unfavorable sanitary and hygienic conditions. This article analyzes the clinical case of a patient who recently returned from India and developed a combined course of typhoid fever and leptospirosis due to astrovirus infection and blastocystosis. The disease was characterized by symptoms of enteritis, low-grade fever, and mild intoxication. The patient repeatedly sought medical help. Diagnoses of “acute respiratory viral infection” and “intestinal infection of unknown etiology” were established. Symptomatic therapy was performed without a positive effect; fever and severe asthenic syndrome persisted. The patient was hospitalized on the 18th day of illness with moderate severity. Taking into account clinical, anamnestic, and epidemiological data and laboratory examination results, typhoid fever was diagnosed. A polymerase chain reaction (PCR) test identified astrovirus RNA in the stool, and Blastocystis hominis was detected during stool examination. Despite the ongoing pathogenetic and antibacterial therapy, considering the determination of the pathogen’s sensitivity to antibiotics, the patient’s condition worsened. On day 23 of the illness, jaundice, hemorrhagic syndrome, and signs of acute renal failure were noted. Through in-depth analysis of changes in the clinical and laboratory findings, considering epidemiological history data (stay in a region endemic for leptospirosis), leptospirosis was diagnosed and treated with antibacterial therapy. Complex intensive therapy using extracorporeal treatment methods helped prevent the development of unfavorable outcomes of combined pathology. This clinical case emphasizes that doctors must be wary of imported infections and conduct additional comprehensive investigations of suspected cases.
- Open Access
- 1 October 2020
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 10 (4) , 664-670
STRONGYLOIDIASIS IN CLINICAL PRACTICE: CHALLENGES IN DIAGNOSTICS AND TREATMENT (BRIEF REVIEW AND CLINICAL OBSERVATIONS)
High priority of soil-transmitted helminths worldwide and in the Russian Federation is due to their vast distribution and the severe pathological features they induce in humans. Recently, it was observed that awareness of clinicians regarding this disease category was markedly decreased, although no significant decline of the disease occurrence has been recorded, whereas rate of imported cases of parasitic diseases including soil-transmitted helminths like strongyloidiasis mainly originating from subtropical or tropical countries rose in non-endemic regions. Lack of alertness on diseases like strongyloidiasis impedes timely diagnostics and treatment. Global prevalence of strongyloidiasis was estimated to range within 30-100 million people, however the World Health Organization (WHO) suggests that it was underestimated as precise data in endemic countries remain unknown. The occurrence of these helminths has been recorded in regions of temperate-continental climate: Western Ukraine, Belarus, Moldova, the Caucasus, Central Asia, as well as in Eastern Europe and the Mediterranean region. In the Russian Federation locally acquired infections are frequently recorded in the Krasnodar Territory and Rostov Region. Here, based on multi-year experience in management of patients with strongyloidiasis we present our data and brief review of publications and systematic literature related to the challenges of its clinical picture, diagnostics and treatment. Life cycle, basic biological parameters of free-living helm inth in nature and distinctive features of autoinfection related to strongyloidiasis were reviewed. Special attention was paid to the risk of developing severe forms (hyperinfection and disseminated strongyloidiasis) especially in immunocompromised hosts: HIV infection, radiotherapy followed by chemotherapy, long-term corticosteroid use. Difficulties in diagnosing Strvngybides stercoralis infection are due to its polymorphic and non-specific clinical manifestations, as well as the lack of clinical knowledge and awareness about the disease. Clinical importance of parasitological methods for larvae detection was underlined. It was noted that the drug of choice in therapy of strongyloidiasis is ivermectin unapproved yet in Russia, whereas albendazole as an alternative drug exerts poorer efficacy, justifying a need to repeat treatment courses to establish full recovery from the disease.
- 1 October 2020
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 10 (4) , 664-670
Open AccessSTRONGYLOIDIASIS IN CLINICAL PRACTICE: CHALLENGES IN DIAGNOSTICS AND TREATMENT (BRIEF REVIEW AND CLINICAL OBSERVATIONS)
High priority of soil-transmitted helminths worldwide and in the Russian Federation is due to their vast distribution and the severe pathological features they induce in humans. Recently, it was observed that awareness of clinicians regarding this disease category was markedly decreased, although no significant decline of the disease occurrence has been recorded, whereas rate of imported cases of parasitic diseases including soil-transmitted helminths like strongyloidiasis mainly originating from subtropical or tropical countries rose in non-endemic regions. Lack of alertness on diseases like strongyloidiasis impedes timely diagnostics and treatment. Global prevalence of strongyloidiasis was estimated to range within 30-100 million people, however the World Health Organization (WHO) suggests that it was underestimated as precise data in endemic countries remain unknown. The occurrence of these helminths has been recorded in regions of temperate-continental climate: Western Ukraine, Belarus, Moldova, the Caucasus, Central Asia, as well as in Eastern Europe and the Mediterranean region. In the Russian Federation locally acquired infections are frequently recorded in the Krasnodar Territory and Rostov Region. Here, based on multi-year experience in management of patients with strongyloidiasis we present our data and brief review of publications and systematic literature related to the challenges of its clinical picture, diagnostics and treatment. Life cycle, basic biological parameters of free-living helm inth in nature and distinctive features of autoinfection related to strongyloidiasis were reviewed. Special attention was paid to the risk of developing severe forms (hyperinfection and disseminated strongyloidiasis) especially in immunocompromised hosts: HIV infection, radiotherapy followed by chemotherapy, long-term corticosteroid use. Difficulties in diagnosing Strvngybides stercoralis infection are due to its polymorphic and non-specific clinical manifestations, as well as the lack of clinical knowledge and awareness about the disease. Clinical importance of parasitological methods for larvae detection was underlined. It was noted that the drug of choice in therapy of strongyloidiasis is ivermectin unapproved yet in Russia, whereas albendazole as an alternative drug exerts poorer efficacy, justifying a need to repeat treatment courses to establish full recovery from the disease.
- Open Access
- 20 March 2020
- Published by Bentham Science Publishers Ltd. in The Open AIDS Journal
- Vol. 14 (1) , 11-15
Clinical Assessment of Nutritional and Metabolic Status in HIV Outpatients
Background: After the World Health Organization’s first technical consultation on Nutrient Requirements for People Living with HIV/AIDS in Geneva, 2003, a lot of research questions that are considered crucial for enhancing our understanding of the interaction of nutrition and HIV infection were raised and until this moment, left unanswered. To gain a better understanding of HIV and nutrition, we implemented a comprehensive approach. The aim of our study was to assess the nutritional and metabolic status in order to enhance the provision of medical care to people living with HIV. Methods: 45 HIV patients and 32 healthy volunteers were enrolled in the study. Within the HIV group, 32 (71%) were male and 13 (29%) female. Only 7 (15%) were ART naïve. Overall their median age, CD4 count and viral load were 30 years (IQR: 28-40), 407 (IQR: 357-490) cells/mm3 and 500 (IQR: 0-1000) copies/ml, respectively. None of the participants in the HIV group had any active infection. Food intake by monthly dietary recall was determined. Body composition was measured using bioelectrical impedance analysis. The selected biochemical parameters were evaluated and the resting metabolic rates were calculated using indirect calorimetry to accurately understand the metabolism of participants. Results: Participants in the HIV group did not meet the recommended daily allowance level (RDA) of carbohydrate requirements. The fat-free mass significantly decreased in the HIV group (P < 0.05). Resting energy expenditure was excessive in the HIV group compared to the control group (P < 0.05). Values of urea nitrogen concentration, fat and protein oxidation rates in the HIV group significantly increased (P < 0.01). The carbohydrate oxidation in the HIV group significantly decreased (P < 0.01) Conclusions: The study reveals a catabolic status in the HIV group and suggests an adjustment in the nutrient RDA to compensate such status. Further investigation should be extended to vulnerable population group particularly children.
- 20 March 2020
- Published by Bentham Science Publishers Ltd. in The Open AIDS Journal
- Vol. 14 (1) , 11-15
Open AccessClinical Assessment of Nutritional and Metabolic Status in HIV Outpatients
Background: After the World Health Organization’s first technical consultation on Nutrient Requirements for People Living with HIV/AIDS in Geneva, 2003, a lot of research questions that are considered crucial for enhancing our understanding of the interaction of nutrition and HIV infection were raised and until this moment, left unanswered. To gain a better understanding of HIV and nutrition, we implemented a comprehensive approach. The aim of our study was to assess the nutritional and metabolic status in order to enhance the provision of medical care to people living with HIV. Methods: 45 HIV patients and 32 healthy volunteers were enrolled in the study. Within the HIV group, 32 (71%) were male and 13 (29%) female. Only 7 (15%) were ART naïve. Overall their median age, CD4 count and viral load were 30 years (IQR: 28-40), 407 (IQR: 357-490) cells/mm3 and 500 (IQR: 0-1000) copies/ml, respectively. None of the participants in the HIV group had any active infection. Food intake by monthly dietary recall was determined. Body composition was measured using bioelectrical impedance analysis. The selected biochemical parameters were evaluated and the resting metabolic rates were calculated using indirect calorimetry to accurately understand the metabolism of participants. Results: Participants in the HIV group did not meet the recommended daily allowance level (RDA) of carbohydrate requirements. The fat-free mass significantly decreased in the HIV group (P < 0.05). Resting energy expenditure was excessive in the HIV group compared to the control group (P < 0.05). Values of urea nitrogen concentration, fat and protein oxidation rates in the HIV group significantly increased (P < 0.01). The carbohydrate oxidation in the HIV group significantly decreased (P < 0.01) Conclusions: The study reveals a catabolic status in the HIV group and suggests an adjustment in the nutrient RDA to compensate such status. Further investigation should be extended to vulnerable population group particularly children.
- Open Access
- 1 January 2020
- Published by LLC Russian Medical Journal in Russian Medical Inquiry
- Vol. 4 (11)
Adult-onset Still’s disease in the clinical practice of infectious disease physician
Adult-onset Still’s disease (AOSD) is a rare multisystem disease of unknown etiology. According to the literature, AOSD incidence in the world is 0.1–0.4 per 100 thousand population and it has two age-related peaks: the first peak — young age (15–25 years), the second — in persons aged 35–46 years. The causes and pathogenetic mechanism of AOSD are not established. The infectious pathology nature has not received proper scientific confirmation. According to modern concepts, this disease belongs to the group of auto-inflammatory, occurring without autoimmune disorders. It was found that patients with AOSD have a T-cell regulation disorder, increased production of the proinflammatory cytokine, the long-term persistence of which leads to the occurrence of fever and aseptic inflammation in various organs and tissues. The main criteria for this nosology are young age, persistent fever, arthritis, maculopapular rash, elevated ferritin level, neutrophilic leukocytosis, seronegative rheumatoid arthritis. Concomitant diseases include polyserositis, lymphadenopathy, hepatosplenomegaly, and nasopharyngeal infection. The article presents a clinical case of AOSD verified in a young woman at the Infectious Diseases Clinical Hospital. The difficulties of diagnostics are described, taking into account the variety of symptoms and the absence of pathognomonic disease signs. KEYWORDS: Adult-onset Still’s disease, fever, auto-inflammatory disease, arthritis, maculopapular rash, ferritin. FOR CITATION: Kharlamova T.V., Smirnova T.Yu., Golub V.P. et al. Adult-onset Still’s disease in the clinical practice of infectious disease physician. Russian Medical Inquiry. 2020;4(11):705–709. DOI: 10.32364/2587-6821-2020-4-11-705-709.
- 1 January 2020
- Published by LLC Russian Medical Journal in Russian Medical Inquiry
- Vol. 4 (11)
Open AccessAdult-onset Still’s disease in the clinical practice of infectious disease physician
Adult-onset Still’s disease (AOSD) is a rare multisystem disease of unknown etiology. According to the literature, AOSD incidence in the world is 0.1–0.4 per 100 thousand population and it has two age-related peaks: the first peak — young age (15–25 years), the second — in persons aged 35–46 years. The causes and pathogenetic mechanism of AOSD are not established. The infectious pathology nature has not received proper scientific confirmation. According to modern concepts, this disease belongs to the group of auto-inflammatory, occurring without autoimmune disorders. It was found that patients with AOSD have a T-cell regulation disorder, increased production of the proinflammatory cytokine, the long-term persistence of which leads to the occurrence of fever and aseptic inflammation in various organs and tissues. The main criteria for this nosology are young age, persistent fever, arthritis, maculopapular rash, elevated ferritin level, neutrophilic leukocytosis, seronegative rheumatoid arthritis. Concomitant diseases include polyserositis, lymphadenopathy, hepatosplenomegaly, and nasopharyngeal infection. The article presents a clinical case of AOSD verified in a young woman at the Infectious Diseases Clinical Hospital. The difficulties of diagnostics are described, taking into account the variety of symptoms and the absence of pathognomonic disease signs. KEYWORDS: Adult-onset Still’s disease, fever, auto-inflammatory disease, arthritis, maculopapular rash, ferritin. FOR CITATION: Kharlamova T.V., Smirnova T.Yu., Golub V.P. et al. Adult-onset Still’s disease in the clinical practice of infectious disease physician. Russian Medical Inquiry. 2020;4(11):705–709. DOI: 10.32364/2587-6821-2020-4-11-705-709.
- Open Access
- 15 November 2019
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 91 (11) , 60-65
Human babesiosis: clinical cases in the european part of the Russian Federation
The article describes four clinical observations of patients with babesiosis detected in the European part of the Russian Federation, two of whom were under the direct supervision of the authors. The analysis of epidemiological data, clinical picture, results of laboratory studies in the dynamics of the disease. Differential diagnosis and treatment are discussed.
- 15 November 2019
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 91 (11) , 60-65
Open AccessHuman babesiosis: clinical cases in the european part of the Russian Federation
The article describes four clinical observations of patients with babesiosis detected in the European part of the Russian Federation, two of whom were under the direct supervision of the authors. The analysis of epidemiological data, clinical picture, results of laboratory studies in the dynamics of the disease. Differential diagnosis and treatment are discussed.